Australia’s share market, or the All Ordinaries Index (INDEXASX: XAO)(ASX: XAO), is currently up 0.40% at lunch.

The AMP Limited (ASX: AMP) share price is down 5.5% with the diversified financial business announcing a large dividend cut as part of its upcoming FY18 result.

Another business showing an even bigger decline is ResMed Inc (ASX: RMD), it is currently down 9.5% after reporting its second quarter result of FY19.


WATCH NOW: The Australian Investors Podcast Feat.
Global Investing Expert Hamish Douglass

Hamish Douglass is one of Australia's top investors and founders, having co-founded Magellan - a near $9 billion business! Learn exactly how Hamish invests in shares today.

iTunes — Soundcloud — Castbox — YouTube — Spotify


At the positive end of the ASX is Iluka Resources Limited (ASX: ILU) which is 7.1% higher as a result of announcing its Pejebu Inaugural Mineral Resource Estimate.

The Auscann Group Holdings Ltd (ASX: AC8) share price is 2.4% higher because it announced it has acquired a research & development facility in Perth for $5.25 million.

Priceline operator Australian Pharmaceutical Industries Ltd (ASX: API) shares are down 6% with it one of the worst fallers in the ASX 200.

TV business Nine Entertainment Co Holdings Ltd (ASX: NEC) shares are up 4.6% at lunch.

NEW! Our #1 ASX ETF of 2019

Exchange-Traded Funds (ETFs) are changing the world of investing. But with so many on the ASX, it's hard to know which ETF will be a top performer in 2019.

Every financial Tom, Dick and Harry seems to 'launching' (read: flogging) an ETF to investors. In our humble opinion, most of them could be a waste of time - and money. Worse, many of them could fail!

Here's the best part: we're willing to release the name and ASX ticker code of the ETF we've identified as our #1 for 2019.

Just click here now to access our free "#1 ETF of 2019" report. No credit card details or payment required.

Disclaimer: Any information contained in this article is limited to general financial/investment advice only. The information has not taken into account your specific needs, goals or objectives, so please consider consulting a licenced and trusted adviser before acting on the information. Please read The Rask Group’s Financial Services Guide (FSG) for more information. This article is authorised by Owen Raszkiewicz of The Rask Group, which is a corporate authorised representative No. 1264179 of Strawman Pty Ltd (ACN: 610 908 211) (AFSL: 501 223).